Incorporating Inflammation into Mortality Risk in Pediatric Acute Respiratory Distress Syndrome

Matt S Zinter1, Benjamin E Orwoll, Aaron C Spicer

  • 11Division of Critical Care, Department of Pediatrics, UCSF School of Medicine, Benioff Children's Hospital, San Francisco, CA. 2Departments of Medicine and Anesthesia, UCSF School of Medicine, Cardiovascular Research Institute, San Francisco, CA. 3Division of Critical Care, Department of Pediatrics, UCLA Geffen School of Medicine, Mattel Children's Hospital, Los Angeles, CA.

Insights

Elevated pro- and anti-inflammatory cytokines in pediatric acute respiratory distress syndrome are linked to higher mortality and ICU morbidity. These biomarkers improve risk prediction for poor outcomes in children.

Area of Science:

  • Pediatric Critical Care Medicine
  • Immunology
  • Respiratory Medicine

Background:

  • Pediatric acute respiratory distress syndrome (PARDS) involves severe lung injury driven by immune activation and inflammation.
  • Identifying reliable biomarkers for PARDS prognosis is crucial for effective patient management.

Purpose of the Study:

  • To investigate the association between pro- and anti-inflammatory cytokines and mortality in pediatric acute respiratory distress syndrome (PARDS).
  • To determine if these cytokine biomarkers can enhance the risk stratification of poor outcomes in PARDS patients.

Main Methods:

  • A multicenter prospective observational study involving 194 pediatric patients with PARDS.
  • Measured eight pro- and anti-inflammatory cytokines on day 1 of PARDS, correlating them with mortality, ICU morbidity (Pediatric Logistic Organ Dysfunction score), and endothelial injury markers.
  • Utilized logistic regression models to assess predictive capabilities.

Main Results:

  • Elevated levels of Interleukin-6, Interleukin-8, Interleukin-10, Interleukin-18, and Tumor Necrosis Factor-R2 were strongly associated with mortality, ICU morbidity, and endothelial injury.
  • A predictive model incorporating oxygenation index, Interleukin-8, and Tumor Necrosis Factor-R2 demonstrated superior accuracy in predicting mortality or severe morbidity compared to oxygenation index alone (AUC 0.77 vs 0.70).

Conclusions:

  • Pro- and anti-inflammatory cytokines are significant predictors of mortality, ICU morbidity, and endothelial injury in pediatric acute respiratory distress syndrome (PARDS).
  • These cytokine biomarkers substantially improve the risk stratification capabilities of the oxygenation index for predicting adverse outcomes in PARDS.
  • Cytokine profiling may aid in identifying high-risk pediatric patients for targeted therapeutic strategies and clinical trial enrollment.
Abstract

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
564
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
638
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.3K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.3K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
4.4K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.0K